Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stein, Marco
RESURGE, NCT02394626: Surgery for Recurrent Glioblastoma	Recruiting	2	120	Europe	Surgery followed by adjuvant second-line therapy, Second-line therapy alone	Insel Gruppe AG, University Hospital Bern, European Organisation for Research and Treatment of Cancer - EORTC	Glioblastoma	12/25	12/25
Oliver, Schnell
RESURGE, NCT02394626: Surgery for Recurrent Glioblastoma	Recruiting	2	120	Europe	Surgery followed by adjuvant second-line therapy, Second-line therapy alone	Insel Gruppe AG, University Hospital Bern, European Organisation for Research and Treatment of Cancer - EORTC	Glioblastoma	12/25	12/25
Neidert, Nicolas Noel
RESURGE, NCT02394626: Surgery for Recurrent Glioblastoma	Recruiting	2	120	Europe	Surgery followed by adjuvant second-line therapy, Second-line therapy alone	Insel Gruppe AG, University Hospital Bern, European Organisation for Research and Treatment of Cancer - EORTC	Glioblastoma	12/25	12/25